Integrating metagenomics with metabolomics for gut microbiota and metabolites profiling in acute pancreatitis/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-11-4

Curated date: 2024/10/31

Curator: KateRasheed

Revision editor(s): KateRasheed

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Acute pancreatitis acute necrotizing pancreatitis,acute pancreatic necrosis,acute pancreatitis,acute pancreatitis (disorder) [ambiguous],pancreatitis necrotizing,pancreatitis, acute,Acute pancreatitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Caeurulein group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Caerulein group was induced by hourly intraperitoneal (i.p.) injection of caerulein (200 μg/kg, once an hour for a total of 10 times).

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
MGISEQ-2000

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-11-4

Curated date: 2024/10/31

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Table S1

Description: Differential abundance in the gut microbiota between control group and caerulein group

Abundance in Group 1: increased abundance in Caeurulein group

NCBI Quality ControlLinks
Kiritimatiellota
Ignavibacteriota
Basidiomycota
Pseudomonadota
Calditrichota
Elusimicrobia
Gemmatimonadota
Candidatus Cloacimonadota
Chrysiogenota
Lentisphaerota
Verrucomicrobiota
Chlorobiota
Fibrobacterota
Candidatus Zixiibacteriota
Bacteroidota
Planctomycetota
Balneolota
Armatimonadota
Acidobacteriota

Revision editor(s): KateRasheed

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-11-4

Curated date: 2024/10/31

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Table S1

Description: Differential abundance in the gut microbiota between control group and caerulein group

Abundance in Group 1: decreased abundance in Caeurulein group

NCBI Quality ControlLinks
Thermoproteota
Aquificota
Chordata
Thermodesulfobacteriota
Mycoplasmatota
Caldisericota
Nitrososphaerota
Promethearchaeota
Candidatus Gracilibacteria
Fusobacteriota
Dictyoglomota
Bacillota

Revision editor(s): KateRasheed